U.S., Nov. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07944105) titled 'SPARK UPS/MFS: Study Of BET Inhibition With ZEN003694 To Potentiate Anti-Tumor Responses With Radiotherapy To Kickstart Abscopal Effect In Metastatic Undifferentiated Pleomorphic Sarcoma (UPS) And Myxofibrosarcoma (MFS).' on Nov. 16.

Brief Summary: This is a single-center, Phase 1/2 clinical trial evaluating the safety, tolerability, RP2D, and preliminary efficacy of ZEN003694 in combination with RT in patients with metastatic UPS and MFS who have completed first- or second- line doxorubicin-based chemotherapy without disease progression.

Study Start Date: May 31, 2027

Study Type: INTERVENTIONAL

Condition: Undifferentiated Pleom...